Comparative analysis of human microglial models for studies of HIV replication and pathogenesis.
Rai, MA; Hammonds, J; Pujato, M; Mayhew, C; Roskin, K; Spearman, P.
Retrovirology.
2020;
17.
A bivalent, spherical virus-like particle vaccine enhances breadth of immune responses against pathogenic ebola viruses in rhesus macaques.
Singh, K; Marasini, B; Chen, X; Ding, L; Wang, JJ; Xiao, P; Villinger, F; Spearman, P.
Journal of Virology.
2020;
94.
HIV-1 Broadly Neutralizing Antibodies Take the Road Less Traveled, and That Makes All the Difference.
Roskin, K; Spearman, P.
Cell Host and Microbe.
2020;
27:487-488.
Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
Keitel, WA; Voronca, DC; Atmar, RL; Paust, S; Hill, H; Wolff, MC; Bellamy, AR; Belshe, RB; Bernstein, DB; Spearman, PW; et al.
Vaccine.
2019;
37:5535-5543.
Rapid boosting of HIV-1 neutralizing antibody responses in humans following a prolonged immunologic rest period.
Spearman, P; Tomaras, GD; Montefiori, DC; Huang, Y; Elizaga, ML; Ferrari, G; Munir Alam, S; Isaacs, A; Ahmed, H; Hural, J; et al.
Journal of Infectious Diseases.
2019;
219:1755-1765.
Challenges and solutions for instituting an efficient maintenance program for laboratory equipment in Central Asian, and developing world, countries.
Ikranbegiin, R; Schmid, G; Hoos, D; Young, A; Della-Latta, P; Spearman, P; Ramos, A; Alemayehu, B; Achmetova, B; Nauryzova, G; et al.
BMC Public Health.
2019;
19.
The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.
Buffone, C; Kutzner, J; Opp, S; Martinez-Lopez, A; Selyutina, A; Coggings, SA; Studdard, LR; Ding, L; Kim, B; Spearman, P; et al.
Virology.
2019;
531:260-268.
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
Houser, KV; Yamshchikov, GV; Bellamy, AR; May, J; Enama, ME; Sarwar, U; Larkin, B; Bailer, RT; Koup, R; Paskel, M; et al.
PLoS ONE.
2018;
13:e0206837-e0206837.
A novel Ebola virus antibody-dependent cell-mediated cytotoxicity (Ebola ADCC) assay.
Singh, K; Marasini, B; Chen, X; Spearman, P.
Journal of Immunological Methods.
2018;
460:10-16.
Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like Particles.
Rampoldi, A; Crooke, SN; Preininger, MK; Jha, R; Maxwell, J; Ding, L; Spearman, P; Finn, MG; Xu, C.
ACS Chemical Biology.
2018;
13:2329-2338.